1-7 of 7
AVIVIT CAHN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

788-P: The Cardiovascular and Renal Benefits of Dapagliflozin Are Independent of Baseline HbA1c: Analyses from DECLARE-TIMI 58

AVIVIT CAHN, STEPHEN D. WIVIOTT, OFRI MOSENZON, SABINA MURPHY, ERICA L. GOODRICH, DEEPAK L. BHATT, LAWRENCE A. LEITER, DARREN K. MCGUIRE, JOHN WILDING, INGRID A. GAUSE-NILSSON, ANNA MARIA LANGKILDE, MARC S. SABATINE, ITAMAR RAZ
Journal: Diabetes
Diabetes 2021;70(Supplement_1):788-P
https://doi.org/10.2337/db21-788-P
Published: 01 June 2021
View article titled, 788-P: The Cardiovascular and Renal Benefits of Dapagliflozin Are Independent of Baseline HbA1c: Analyses from DECLARE-TIMI 58
Meeting Abstracts

303-OR: Effect of Dapagliflozin on Risk for Fast Decline in EGFR: Analyses from the DECLARE-TIMI 58 Trial

ITAMAR RAZ, STEPHEN D. WIVIOTT, HIDDO L. HEERSPINK, JAMIE P. DWYER, AVIVIT CAHN, ERICA L. GOODRICH, SABINA MURPHY, ALIZA ROZENBERG, ILAN YANUV, JOHN WILDING, LAWRENCE A. LEITER, DEEPAK L. BHATT, DARREN K. MCGUIRE, RONALD C. MA, TSVETALINA TANKOVA, MARTIN FREDRIKSSON, INGRID A. GAUSE-NILSSON, ANNA MARIA LANGKILDE, MARC S. SABATINE, OFRI MOSENZON
Journal: Diabetes
Diabetes 2020;69(Supplement_1):303-OR
https://doi.org/10.2337/db20-303-OR
Published: 01 June 2020
View article titled, 303-OR: Effect of Dapagliflozin on Risk for Fast Decline in EGFR: Analyses from the DECLARE-TIMI 58 Trial
Meeting Abstracts

1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58

AVIVIT CAHN, STEPHEN D. WIVIOTT, OFRI MOSENZON, SABINA MURPHY, ERICA L. GOODRICH, ILAN YANUV, ALIZA ROZENBERG, JOHN WILDING, LAWRENCE A. LEITER, DEEPAK L. BHATT, DARREN K. MCGUIRE, LEON LITWAK, ADRIAAN KOOY, INGRID A. GAUSE-NILSSON, MARTIN FREDRIKSSON, ANNA MARIA LANGKILDE, MARC S. SABATINE, ITAMAR RAZ
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1101-P
https://doi.org/10.2337/db20-1101-P
Published: 01 June 2020
View article titled, 1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58
Meeting Abstracts

244-OR: Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial

ITAMAR RAZ, STEPHEN D. WIVIOTT, ILAN YANUV, ALIZA ROZENBERG, THOMAS A. ZELNIKER, AVIVIT CAHN, HIDDO L. HEERSPINK, JAMIE P. DWYER, ERICA GOODRICH, DEEPAK L. BHATT, LAWRENCE A. LEITER, DARREN K. MCGUIRE, JOHN P. WILDING, INGRID ANNA GAUSE-NILSSON, MARTIN FREDRIKSSON, PETER A. JOHANSSON, ANNA MARIA LANGKILDE, MARC S. SABATINE, OFRI MOSENZON
Journal: Diabetes
Diabetes 2019;68(Supplement_1):244-OR
https://doi.org/10.2337/db19-244-OR
Published: 01 June 2019
View article titled, 244-OR: Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial
Meeting Abstracts

236-OR: Effects of Dapagliflozin on Progression of Diabetic Kidney Disease: Analysis from DECLARE-TIMI 58 Trial

OFRI MOSENZON, STEPHEN D. WIVIOTT, THOMAS A. ZELNIKER, HIDDO L. HEERSPINK, JAMIE P. DWYER, AVIVIT CAHN, INGRID ANNA GAUSE-NILSSON, ANNA MARIA LANGKILDE, MARC S. SABATINE, ITAMAR RAZ
Journal: Diabetes
Diabetes 2019;68(Supplement_1):236-OR
https://doi.org/10.2337/db19-236-OR
Published: 01 June 2019
View article titled, 236-OR: Effects of Dapagliflozin on Progression of Diabetic Kidney Disease: Analysis from DECLARE-TIMI 58 Trial
Meeting Abstracts

Feasibility of Creating a Diagnosis-Based Diabetic Foot Registry in a Large Health Care Provider

AVIVIT CAHN, TALYA ALTARAS, TAL AGAMI, SR., ORI LIRAN, COLETTE E. TOUATY, RENA POLLACK, ITAMAR RAZ, GABRIEL CHODICK, INBAR ZUCKER
Journal: Diabetes
Diabetes 2018;67(Supplement_1):636-P
https://doi.org/10.2337/db18-636-P
Published: 01 July 2018
View article titled, Feasibility of Creating a Diagnosis-Based Diabetic Foot Registry in a Large Health Care Provider
Meeting Abstracts

Use of a Machine Learning Algorithm Improves Prediction of Progression to Diabetes

AVIVIT CAHN, AVI SHOSHAN, TAL SAGIV, RACHEL YESHARIM, ITAMAR RAZ, RAN GOSHEN
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1286-P
https://doi.org/10.2337/db18-1286-P
Published: 01 July 2018
View article titled, Use of a Machine Learning Algorithm Improves Prediction of Progression to Diabetes